1249 Treatment interruptions for immune related adverse events and overall survival in patients with non-small cell lung cancer (NSCLC) treated with first line immune checkpoint inhibitors (ICI)
Regular and Young Investigator Award Abstracts（2022）
关键词
immune checkpoint inhibitors,cell lung cancer,lung cancer,treatment interruptions,non-small
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要